{"id":"https://openalex.org/A5135091908","orcid":null,"observed_orcids":[],"display_name":"Ningfang Kang","raw_author_names":["Ningfang Kang"],"full_name":"Ningfang Kang","works_count":1,"cited_by_count":3,"summary_stats":{"2yr_mean_citedness":3.0,"h_index":1,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5135091908","orcid":null,"observed_orcids":[]},"affiliations":[{"institution":{"id":"https://openalex.org/I161716053","ror":"https://ror.org/01sfm2718","display_name":"China Pharmaceutical University","country_code":"CN","type":"education","lineage":["https://openalex.org/I161716053"]},"years":[2026]}],"last_known_institutions":[{"id":"https://openalex.org/I161716053","ror":"https://ror.org/01sfm2718","display_name":"China Pharmaceutical University","country_code":"CN","type":"education","lineage":["https://openalex.org/I161716053"]}],"topics":[{"id":"https://openalex.org/T10274","display_name":"Synthesis and biological activity","count":1,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10782","display_name":"Nanoplatforms for cancer theranostics","count":1,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","count":1,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"topic_share":[{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","value":7.2e-06,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10782","display_name":"Nanoplatforms for cancer theranostics","value":6.1e-06,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Synthesis and biological activity","value":2.9e-06,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"x_concepts":[{"id":"109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","score":0.5142999887466431},{"id":"185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","score":0.4465000033378601},{"id":"197336794","wikidata":"https://www.wikidata.org/wiki/Q5161150","display_name":"Conjugate","score":0.27059999108314514},{"id":"121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","score":0.25940001010894775},{"id":"116073593","wikidata":"https://www.wikidata.org/wiki/Q864491","display_name":"Biological activity","score":0.2515999972820282}],"counts_by_year":[{"year":2026,"works_count":1,"oa_works_count":0,"cited_by_count":3}],"display_name_alternatives":["Ningfang Kang"],"block_key":"n kang","works_api_url":"https://api.openalex.org/works?filter=author.id:A5135091908","updated_date":"2026-10-13T12:33:52","created_date":"2026-05-04T00:00:00"}